Publication | Closed Access
Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment
28
Citations
37
References
2018
Year
Chk1 Inhibitor Mk-8776MedicineMetronomic TherapyPharmacologyMetronomic Oral DoxorubicinBreast CancerAnti-cancer AgentMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1